YIDU TECH(02158) has been buying back shares for 7 consecutive days, with a total expenditure of over 22.7 million Hong Kong dollars.

On February 3, YIDU TECH (02158) announced its latest stock repurchase announcement. The company repurchased over 1.46 million shares at a price of approximately HK$5.6 per share on the same day, with a total expenditure of over HK$8 million, once again setting a new record for the highest daily repurchase amount in recent times, demonstrating the company's strong determination to increase repurchases and boost market confidence. As of February 3, YIDU TECH has conducted stock repurchases intensively for seven consecutive trading days, with a cumulative repurchase amount exceeding HK$22.7 million. Huajin Securities released a new research report pointing out that AI technology has gradually penetrated the entire industry chain of medical health, greatly improving the efficiency and quality of medical services, from drug development, clinical trials, drug promotion in the pharmaceutical industry, to the entire lifecycle of diagnosis, treatment, and post-treatment. At the same time, multiple ministries have successively issued policies to promote the application of artificial intelligence in the medical field, and local policy pilots are progressing steadily. Huajin Securities believes that in the future, with the continuous landing of large models in the medical field, the prosperity of the AI+ medical industry will continue to rise. As a veteran in the AI medical industry, YIDU TECH's business has been steadily improving. Recently, it has successively promoted the landing of diagnostic assistants and innovative health management systems in Chongqing, Shenzhen, and other places. Market analysis believes that the continuous repurchase operations, along with signals of fundamental improvement and progress in diversified businesses, resonate, further strengthening market recognition of its strategic execution efficiency and long-term investment value.